Ally Bridge Group (NY) LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001822947

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 22 positions · Total reported value $137.20M · Top-10 concentration 73.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.9% · 4 new · 6 cut · 12 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.8% · vs SPY -17.9% · Prev Value $113.07M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -16.4% · vs SPY -18.5% · Latest Value $75.30M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Ally Bridge Group (NY) LLC disclosed 22 equity positions with a combined reported value of $137.20M. The filing implies a focused portfolio: its ten largest positions account for 73.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were SLNO ($16.90M), REPL ($15.08M), MDGL ($14.98M). By sector, the heaviest allocations are Health Care 75.8%, Other 24.2%. Versus the prior quarter, allocation shifted toward Health Care (+17.3pp) and away from Other (-17.3pp).

Versus the prior quarter, Ally Bridge Group (NY) LLC opened 4 new positions, trimmed 6 and fully exited 12, a turnover rate of 75.9% of positions. The portfolio's overlap with the prior quarter was 39% of names.

The largest new positions opened in Q3 2025 were MDGL ($14.98M), ATAI ($12.10M), ASND ($10.16M).

Of the 12 positions fully exited versus the prior quarter, the largest were VRNA ($15.20M), MRUS ($7.37M), RARE ($5.82M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • MDGL MADRIGAL PHARMACEUTICALS INC · $14.98M
  • ATAI ATAI LIFE SCIENCES NV · $12.10M
  • ASND ASCENDIS PHARMA A/S · $10.16M
  • TSHA TAYSHA GENE THERAPIES INC · $6.21M
  • AMLX AMYLYX PHARMACEUTICALS INC · $5.94M
  • EPRX EUPRAXIA PHARMACEUTICALS INC · $5.40M
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · $4.40M
  • AVTX AVALO THERAPEUTICS INC · $2.26M

Fully Exited (vs previous quarter)

  • VRNA VERONA PHARMA PLC · prev qtr: $15.20M
  • MRUS MERUS N V · prev qtr: $7.37M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $5.82M
  • ELVN ENLIVEN THERAPEUTICS INC · prev qtr: $5.64M
  • ORIC ORIC PHARMACEUTICALS INC · prev qtr: $4.93M
  • INSM INSMED INC · prev qtr: $4.80M
  • GERN GERON CORP · prev qtr: $4.58M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $3.86M

Insider Transactions (Form 4)

Latest Ally Bridge Group (NY) LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Ally Bridge Group (NY) LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 17 US equity positions with a combined value of $75.30M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121984 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $218.95M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds

Portfolio Structure

  • 17 positions · $75.30M reported value (Q3 2026)
  • Top 10 holdings = 88.8% of reported value
  • Largest position: DFTX (DEFINIUM THERAPEUTICS INC) at 20.2%
  • Average position size: $4.43M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 2 added, 6 reduced, 12 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 75.8%
Other 24.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 250.00K $16.90M 12.32%
12.32%
Add
2 3.60M $15.08M 10.99%
10.99%
Add
3 32.66K $14.98M 10.92%
10.92%
New
4 2.29M $12.10M 8.82%
8.82%
New
5 51.08K $10.16M 7.40%
7.40%
New
6 175.36K $8.17M 5.95%
5.95%
Reduce
7 1.90M $6.21M 4.52%
4.52%
New
8 437.39K $5.94M 4.33%
4.33%
New
9 1.03M $5.88M 4.29%
4.29%
Reduce
10 915.00K $5.40M 3.94%
3.94%
New
11 100.00K $5.30M 3.86%
3.86%
Add
12 64.45K $5.26M 3.84%
3.84%
Add
13 233.22K $4.40M 3.20%
3.20%
New
14 361.44K $4.26M 3.11%
3.11%
Reduce
15 70.78K $4.21M 3.07%
3.07%
Reduce
16 549.18K $3.39M 2.47%
2.47%
Reduce
17 6.23M $2.65M 1.93%
1.93%
Add
18 178.10K $2.26M 1.65%
1.65%
New
19 138.59K $2.17M 1.58%
1.58%
Reduce
20 817.94K $1.55M 1.13%
1.13%
Hold
21 69.00K $494.73K 0.36%
0.36%
New
22 600.00K $432.84K 0.32%
0.32%
Add

FAQ

What did Ally Bridge Group (NY) LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, Ally Bridge Group (NY) LLC reported 22 equity positions worth $137.20M in aggregate; its largest disclosed positions were SLNO ($16.90M), REPL ($15.08M), MDGL ($14.98M).

How large is Ally Bridge Group (NY) LLC's portfolio?

Ally Bridge Group (NY) LLC reported $137.20M of long equity holdings across 22 positions as of 2025-Q3. Top-10 holdings account for 73.5% of reported value.

What is Ally Bridge Group (NY) LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ally-bridge-group-ny/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →